Aledade company profile: valuation, funding & revenue

This Aledade company profile covers the company's valuation, revenue, funding rounds, investors and history. Aledade works in healthcare, with a focus on value-based primary care. It was founded in 2014 and is headquartered in Bethesda, Maryland, United States. Its latest valuation on record is US$3.5 billion (reported) (June 2023). Every figure links to a public source, and anything the company hasn't disclosed is marked as such.

Revenue

Funding history

Aledade timeline

Key dates from the sources on this page, oldest first. Metric snapshots are listed after the funding events.

• 2014 — Aledade is founded in Bethesda by Farzad Mostashari (CEO) and co-founders.
• Jun 2023 — Series F: US$260M, valuing the company at US$3.5B (reported). Investors: Lightspeed Venture Partners (lead); Venrock, Avidity Partners, OMERS Growth Equity, Fidelity.
• Late 2025 — Credit facility: US$500M. Investors: Lenders not listed here.
• December 2025 — Credit facility: US$500 million credit facility to support growth.

Investors

Overview

Aledade helps independent primary care practices succeed in value-based care, where doctors are rewarded for keeping patients healthy and reducing unnecessary spending rather than for the number of visits or procedures. It forms and runs accountable care organisations (ACOs) that bring together independent practices, community health centres and rural clinics, provides them with data, software and on-the-ground support, and shares in the savings they generate for Medicare, Medicaid and commercial insurers. Aledade has become one of the largest networks of independent primary care in the United States. In June 2023 it raised a US$260 million Series F led by Lightspeed Venture Partners, which Bloomberg reported valued it at US$3.5 billion.

Farzad Mostashari, the CEO, co-founded Aledade in 2014. Mostashari, a physician and epidemiologist, previously served as the US National Coordinator for Health Information Technology, overseeing the national push to adopt electronic health records. He founded Aledade to help independent doctors, who were often being acquired by hospitals and health systems, remain independent while delivering better care at lower cost.

Products and services

• ACO management: forming and operating accountable care organisations that contract with Medicare and other payers.
• Aledade App: software that pulls together claims and clinical data to show which patients need attention, such as preventive care or follow-up after hospital stays.
• Practice support: field teams that help practices change workflows, coding and care management.
• Care management: nurses and care coordinators who support high-risk patients.
• Payer contracts: value-based agreements with Medicare Advantage, Medicaid and commercial plans.

Funding

Aledade raised earlier rounds from investors including Venrock and ARCH Venture Partners. In June 2023 it announced a US$260 million Series F led by Lightspeed Venture Partners, with Venrock, Avidity Partners, OMERS Growth Equity and Fidelity participating, to accelerate growth, enhance technology and pursue acquisitions. Bloomberg reported, citing people familiar with the matter, that the deal valued Aledade at US$3.5 billion; the company didn't state a valuation, so we label it as reported. In December 2025 Aledade closed a US$500 million credit facility to support further expansion.

Business model

Aledade earns revenue mainly by sharing in the savings its practice partners achieve under value-based contracts. When a network of practices keeps total spending for its patients below a benchmark while meeting quality standards, the payer shares part of the savings, which Aledade splits with the practices. Some contracts involve downside risk, meaning losses if spending exceeds targets. Its revenue therefore depends on how well practices manage care and on the design of government and insurer programmes.

Competition

Aledade competes with other companies that enable value-based care for physicians, such as agilon health, Privia Health and Evolent, and with health systems and insurers that employ or partner with primary care doctors, such as Optum. It also competes with value-based primary care companies such as Oak Street Health and Cityblock Health that run their own clinics. Its focus on keeping practices independent sets it apart.

Aledade at a glance

Aledade is a Bethesda, Maryland, value-based care company co-founded in 2014 by Farzad Mostashari, former US National Coordinator for Health IT. It forms and runs accountable care organisations for independent primary care practices, providing data, software and support. It raised a US$260 million Series F in June 2023 led by Lightspeed, at a reported US$3.5 billion valuation.

Timeline

• 2014: founded.
• 2015–2020: builds ACOs across many states.
• June 2023: raises US$260 million at a reported US$3.5 billion.
• December 2025: closes a US$500 million credit facility.

How an ACO works

In Medicare's accountable care programmes, a group of doctors and other providers takes responsibility for the overall cost and quality of care for a population of patients. If the group keeps spending below a target while meeting quality measures, it earns a share of the savings. To do this, practices focus on preventive care, managing chronic conditions such as diabetes and heart failure, following up after hospital discharge and avoiding unnecessary emergency visits and tests. Independent practices often lack the data and staff to manage this, which is where Aledade's software and support come in.

Why independent practices matter

Over the past two decades, many independent physician practices have been bought by hospitals and large health companies. Research suggests that such consolidation can increase prices. Independent practices can be more nimble and connected to their communities but often struggle with administrative burdens and the investment needed for value-based care. Aledade's model aims to give them the tools to succeed without selling, which appeals to policymakers concerned about consolidation.

Who funds Aledade

Aledade's investors include Lightspeed Venture Partners, which led its Series F, Venrock, ARCH Venture Partners, Avidity Partners, OMERS Growth Equity and Fidelity.

Who uses Aledade

Aledade partners with independent primary care practices, community health centres and rural health clinics across many US states, along with payers including Medicare, Medicaid managed care plans and commercial insurers.

Valuation context

Aledade's reported valuation came after many value-based care companies had seen their valuations fall in public markets. Our guide to health tech unicorns compares it with peers.

Risks

• Policy dependence: changes to Medicare programmes affect revenue.
• Financial risk: downside risk contracts can produce losses.
• Medical cost trends: rising utilisation can erode savings.
• Competition: many enablers compete for independent practices.

Questions for practices

• How are shared savings split, and is there downside risk?
• What support and staff does Aledade provide?
• How does its software fit with your electronic health record?

For practices considering a partner, it helps to speak with doctors already in the network about the support they receive and how shared savings have worked in practice.

Patients usually notice the changes as more proactive outreach, such as reminders for screenings and follow-up calls after hospital visits.

Latest developments (October 2026)

Aledade has relied on debt rather than new equity since its 2023 Series F, which Bloomberg reported valued it at about US$3.5 billion. It closed a US$500 million credit facility to fund growth, according to Fierce Healthcare, and data providers date the facility to late 2025. It also made senior commercial hires in 2026. The value-based care sector has faced pressure from changes to Medicare Advantage payments, which makes Aledade's model of supporting independent primary care practices in accountable care organisations a closely watched test of the sector.

What to watch

Watch Medicare policy changes, network growth, acquisitions and any IPO plans.

Takeaways

Independent doctors can succeed in value-based care without selling their practices. Founders can see how policy expertise can shape a company. Investors should watch Medicare policy.

Sources

Every figure on this page comes from the public sources below. Where sources disagreed, we used the company's own announcement or a primary news report. Private-company data changes; check the date beside each figure.

1. MobiHealthNews (citing Bloomberg)
2. Fierce Healthcare
3. Aledade (company announcement)